EMERGING PUBLIC BIOTECH

EMERGENT BIOSOLUTIONS INC (EBS)

Gaithersburg, United States · North America
EMERGING PUBLIC BIOTECH
HEADQUARTERS
Gaithersburg, United States
TICKER
EBS
SEGMENT
Emerging Public Biotech
THERAPY AREAS
KEY PRODUCTS
PRODUCTDETAILS
ACAM2000
COMPANY OVERVIEW

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intravenous (ANTHRASIL), a polyclonal antibody therapeutic for the treatment of inhalational anthrax; Botulism Antitoxin Heptavalent (BAT), an equine plasma antitoxin for the treatment of symptomatic botulism; BioThrax, an anthrax vaccine; CYFENDUS, a vaccine for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis; Ebanga, a monoclonal antibody for the tre…

EMERGENT BIOSOLUTIONS INC — FULL INTELLIGENCE

Live regulatory signals, patent cliffs, financials, tariff exposure and pipeline — all free on PharmaSignal.

OPEN PLATFORM →